Affiliation:
1. SMBT Dental College and Hospital, Sangamner, Maharashtra, India
Abstract
The pathogenesis of neuropsychiatric disorders is incompletely understood, which may partly account for the persisting dominance of the syndrome nosology in neuropsychiatry, despite its widely recognized inadequacies. Oxidative stress mechanism have been implicated in the pathogenesis has theoretical appeal, as the brain is considered particularly vulnerable to the damage. The oxidative vulnerability of the brain, suggests that oxidative damage may be a plausible pathogenic candidate. Antioxidants have attracted the attention of clinicians due to therapeutic potential. The author presents an overview of the current literature on antioxidants supplementation approach, particularly vitamin E and C and current evidences in the field of neuropsychiatric disorders. Vitamin E and vitamin C are well known antioxidants that are postulated to protect against damage to biological membranes by their ability to scavenge free radicals. Results of vitamin combinations are found promising and further studies on this combination therapy are suggested.
Publisher
IP Innovative Publication Pvt Ltd
Reference52 articles.
1. Schyf CJ Van Der, Geldenhuys WJ, Youdim MBH, Multifunctional drugs with different CNS targets for neuropsychiatric disorders.J Neurochem 2006;99(4):1033-81
2. Kumari R, Chatterjee M, Singh S, Kaundal M, Oxidative stress: a novel treatment target in psychiatric disorder.Trends Pharmacol Sci 2011;29(7):165-72
3. Lackovic M, Rovcanin B, Pantovic M, Ivkovi M C, Association of oxidative stress with THE pathophysiology of depression and bipolar disorder.Arch Biol Sci 2013;65(1):369-73
4. Popa-Wagner A, Mitran S, Sivanesan S, Ros Chang E, Diseases Brain, The Good, the Bad, and the Ugly.Oxidative Medicine and Cellular Longevity.
5. Bayani U, Singh A V, Zamboni P, Mahajan R T, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.Current Neuropharmacology 2009;7:65-74